HuGE Literature Finder
Records 1-25
|
Association between MTHFR Ala222Val (rs1801133) polymorphism and bladder cancer susceptibility: a systematic review and meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Oct 34 (5): 2565-72. Li Kai, Hu Yong ping, Yang Zecheng, Sun Tongx |
|
MTHFR C677T and A1298C polymorphisms were associated with bladder cancer risk and disease progression: a meta-analysis.
DNA and cell biology 2013 May 32 (5): 260-7. You Wu, Li Zuo, Jing Chen, Qian-Wei Xing, Yu-Ping Zhang, Weng-Guang Li, Hua-Lei |
|
Quantitative assessment of the association between MHTFR C677T (rs1801133, Ala222Val) polymorphism and susceptibility to bladder cancer.
Diagnostic pathology 2013 8 (1): 95. Xu Wei, Zhang Haifeng, Wang Fa, Wang Hongh |
|
Relationships among MTHFR a1298c Gene Polymorphisms and Methylation Status of Dact1 Gene in Transitional Cell Carcinomas.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (10): 10. Cheng H, Lu M, Mao LJ, Wang JQ, Li W, Wen RM, Chen JC |
|
Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.
Environmental health : a global access science source 2012 11 (1): 43. Beebe-Dimmer Jennifer L, Iyer Priyanka T, Nriagu Jerome O, Keele Greg R, Mehta Shilpin, Meliker Jaymie R, Lange Ethan M, Schwartz Ann G, Zuhlke Kimberly A, Schottenfeld David, Cooney Kathleen |
|
Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.
Medical oncology (Northwood, London, England) 2011 Dec 28 Suppl 1 S398-412. Safarinejad Mohammad Reza, Shafiei Nayyer, Safarinejad Shi |
|
Smoking and polymorphisms in folate metabolizing genes and their effects on the histological stage and grade for bladder tumors.
Bulletin du cancer 2011 Feb 98 (2): E1-10. Rouissi Kamel, Stambouli Najla, Marrakchi Raja, Slama Mohamed R Ben, Cherif Mohamed, Sfaxi Mohamed, Chebil Mohamed, Elgaaied Amel Benammar, Ouerhani Sl |
|
MTHFR gene polymorphisms and bladder cancer susceptibility: a meta-analysis including race, smoking status and tumour stage.
Asian Pacific journal of cancer prevention : APJCP 2011 12 (9): 2227-32. Kouidhi Soumaya, Rouissi Kamel, Khedhiri Sami, Ouerhani Slah, Cherif Mohamed, Benammar-Elgaaied Am |
|
MTHFR gene polymorphisms in bladder cancer in the Turkish population.
Asian Pacific journal of cancer prevention : APJCP 2011 12 (7): 1833-5. Izmirli Muzeyyen, Inandiklioglu Nihal, Abat Deniz, Alptekin Davut, Demirhan Osman, Tansug Zuhtu, Bayazit Yildir |
|
Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma.
Cancer causes & control : CCC 2010 Oct 21 (10): 1605-13. Chung Chi-Jung, Pu Yeong-Shiau, Su Chien-Tien, Chen Hui-Wen, Huang Yung-Kai, Shiue Horng-Sheng, Hsueh Yu-M |
|
Genetic susceptibility to distinct bladder cancer subphenotypes.
European urology 2010 Feb 57 (2): 283-92. Guey Lin T, García-Closas Montserrat, Murta-Nascimento Cristiane, Lloreta Josep, Palencia Laia, Kogevinas Manolis, Rothman Nathaniel, Vellalta Gemma, Calle M Luz, Marenne Gaëlle, Tardón Adonina, Carrato Alfredo, García-Closas Reina, Serra Consol, Silverman Debra T, Chanock Stephen, Real Francisco X, Malats Núria, |
|
Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population.
Cancer genetics and cytogenetics 2009 Nov 195 (1): 43-53. Rouissi Kamel, Ouerhani Slah, Oliveira Elisabete, Marrakchi Raja, Cherni Lotfi, Ben Othman Fethi, Ben Slama Mohamed R, Sfaxi Mohamed, Ayed Mohsen, Chebil Mohamed, Amorim António, Prata Maria João, Benammar Elgaaied Am |
|
Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population.
Cancer detection and prevention 2009 32 (5-6): 5-6. Ouerhani S, Rouissi K, Marrakchi R, Ben Slama MR, Sfaxi M, Chebil M, ElGaaied AB |
|
Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case-control study with meta-analysis.
Clinical and experimental medicine 2009 Mar 9 (1): 9-19. Wang Meilin, Zhu Haixia, Fu Guangbo, Wang Miaomiao, Zhang Zhizhong, Lu Qiang, Wang Shizhi, Zhang Zhengdo |
|
Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007 Jul 18 (7): 1230-42. Vineis P, Veglia F, Garte S, Malaveille C, Matullo G, Dunning A, Peluso M, Airoldi L, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen J P, Kaaks R, Boeing H, Trichopoulou A, Palli D, Crosignani P, Tumino R, Panico S, Bueno-De-Mesquita H B, Peeters P H, Lund E, Gonzalez C A, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros J R, Berglund G, Jarvholm B, Day N E, Key T J, Saracci R, Riboli E, Autrup |
|
Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population.
Cancer genetics and cytogenetics 2007 Jul 176 (1): 48-53. Ouerhani Slah, Oliveira Elisabete, Marrakchi Raja, Ben Slama Mohamed R, Sfaxi Mohamed, Ayed Mohsen, Chebil Mohamed, Amorim António, El Gaaied Amel Benammar, Prata Maria Jo |
|
Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer.
International journal of cancer. Journal international du cancer 2007 Jun 120 (11): 2452-8. Moore Lee E, Malats Núria, Rothman Nathaniel, Real Francisco X, Kogevinas Manolis, Karami Sara, García-Closas Reina, Silverman Debra, Chanock Stephen, Welch Robert, Tardón Adonina, Serra Consol, Carrato Alfredo, Dosemeci Mustafa, García-Closas Montserr |
|
Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic.
Journal of toxicology and environmental health. Part A 2007 Jan 70 (2): 159-70. Steinmaus Craig, Moore Lee E, Shipp Miriam, Kalman David, Rey Omar A, Biggs Mary L, Hopenhayn Claudia, Bates Michael N, Zheng Shichun, Wiencke John K, Smith Allan |
|
Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms.
Scandinavian journal of urology and nephrology 2007 41 (3): 182-90. Sanyal Somali, Ryk Charlotta, De Verdier Petra J, Steineck Gunnar, Larsson Per, Onelöv Erik, Hemminki Kari, Kumar Raj |
|
Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours.
Cancer letters 2006 Sep 241 (1): 142-9. Ryk Charlotta, Kumar Rajiv, Sanyal Somali, de Verdier Petra J Berggren, Hemminki Kari, Larsson Per, Steineck Gunnar, Hou Sai-M |
|
Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study.
International journal of hygiene and environmental health 2005 208 (5): 321-7. Karagas Margaret R, Park Sunyeong, Nelson Heather H, Andrew Angeline S, Mott Leila, Schned Alan, Kelsey Karl |
|
Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
Carcinogenesis 2004 Sep 25 (9): 1639-47. Lin Jie, Spitz Margaret R, Wang Yunfei, Schabath Matthew B, Gorlov Ivan P, Hernandez Ladia M, Pillow Patricia C, Grossman H Barton, Wu Xife |
|
Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina.
Cancer letters 2004 Aug 211 (2): 199-207. Moore Lee E, Wiencke John K, Bates Michael N, Zheng Shichun, Rey Omar A, Smith Allan |
|
Polymorphisms in DNA repair and metabolic genes in bladder cancer.
Carcinogenesis 2004 May 25 (5): 729-34. Sanyal Somali, Festa Fabiola, Sakano Shigeru, Zhang Zhengzhong, Steineck Gunnar, Norming Ulf, Wijkström Hans, Larsson Per, Kumar Rajiv, Hemminki Ka |
|
Genetic polymorphisms of MTHFR and aberrant promoter hypermethylation of the RASSF1A gene in bladder cancer risk in a Chinese population.
The Journal of international medical research 0 37 (6): 1882-9. Cai D W, Liu X F, Bu R G, Chen X N, Ning L, Cheng Y, Wu |
- Page last reviewed:Mar 16, 2019
- Page last updated:Mar 26, 2020
- Content source: